Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 4209 - 4216 of 12011 results
Seeking FCC Flexibility on the Sale of Wireless Medical Devices During COVID-19
April 22, 2020| Blog| Viewpoint
First Circuit Issues Important Ruling on Valuing Secured Claims in Settled Causes of Action
April 22, 2020| Blog| Viewpoint
Part One of the COVID-19 Roadmap Series: Introduction
April 22, 2020| Blog| Viewpoint
Updated: Summary of the U.S. Department of Labor’s FFCRA Regulations
April 22, 2020| Blog| Viewpoint
Governor Baker Signs Legislation Creating a Temporary Moratorium on Evictions: What Commercial Landlords Need to Know
April 21, 2020| Blog| Viewpoint
FINRA Provides Guidance on Client Communications and Supervision During COVID-19 Pandemic
April 21, 2020| Blog| Viewpoint
In Application of American Express to Horizontal Merger Challenge, District Court Allows Merger of Airline Ticket Platforms
April 21, 2020| Alert| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|